Drug Eluting Stents (Des) Market Report

Europe Drug Eluting Stents (Des) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 15, 2019
  • PAGES：196
  • REPORT CODE：GMM321666
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Drug Eluting Stents (Des) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Drug Eluting Stents (Des) Market Segmentations:

    By Player:

    • Reva Medical

    • Kinhely

    • JW Medical Systems

    • Essen

    • Terumo Medical

    • Translumina

    • Sahajanand

    • Medtronic Vascular

    • Abbott Laboratories

    • Biosensors

    • Sino Medical

    • Advantec Vascular

    • MicroPort Medical

    • Medfavour Medical

    • Abbott Vascular

    • Vascular Concepts

    • B.Braun Melsengen AG

    • Orbusneich

    • Blue Medical

    • MIV Therapeutics

    • Relisys Medical

    • Sorin

    • Boston Scientific

    • Promed Medical

    • Lepu Medical

    • DISA Vascular

    By Type:

    • Cobalt-chromium alloy Stents

    • Magnesium alloy Stents

    • Tyrosine polycarbonate Stents

    • Nitinol Stents

    • Platinum chromium alloy Stents

    • Stainless steel Stents

    • Other Materials

    By End-User:

    • Coronary Heart Disease

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Drug Eluting Stents (Des) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Cobalt-chromium alloy Stents from 2014 to 2026

    • 1.3.2 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Magnesium alloy Stents from 2014 to 2026

    • 1.3.3 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Tyrosine polycarbonate Stents from 2014 to 2026

    • 1.3.4 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Nitinol Stents from 2014 to 2026

    • 1.3.5 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Platinum chromium alloy Stents from 2014 to 2026

    • 1.3.6 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Stainless steel Stents from 2014 to 2026

    • 1.3.7 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Other Materials from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Coronary Heart Disease from 2014 to 2026

    • 1.4.2 Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Drug Eluting Stents (Des) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Drug Eluting Stents (Des) by Major Types

      • 3.4.1 Market Size and Growth Rate of Cobalt-chromium alloy Stents

      • 3.4.2 Market Size and Growth Rate of Magnesium alloy Stents

      • 3.4.3 Market Size and Growth Rate of Tyrosine polycarbonate Stents

      • 3.4.4 Market Size and Growth Rate of Nitinol Stents

      • 3.4.5 Market Size and Growth Rate of Platinum chromium alloy Stents

      • 3.4.6 Market Size and Growth Rate of Stainless steel Stents

      • 3.4.7 Market Size and Growth Rate of Other Materials

    4 Segmentation of Drug Eluting Stents (Des) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Drug Eluting Stents (Des) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Drug Eluting Stents (Des) for Coronary Heart Disease

      • 4.4.2 Market Size and Growth Rate of Drug Eluting Stents (Des) for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Drug Eluting Stents (Des) Production Analysis by Top Regions

    • 5.2 Europe Drug Eluting Stents (Des) Consumption Analysis by Top Regions

    • 5.3 Europe Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Drug Eluting Stents (Des) Market among Top Countries

    • 6.1 Top 5 Export Countries in Drug Eluting Stents (Des) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Drug Eluting Stents (Des) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Drug Eluting Stents (Des) Landscape Analysis

    • 7.1 Germany Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 7.2 Germany Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    8. UK Drug Eluting Stents (Des) Landscape Analysis

    • 8.1 UK Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 8.2 UK Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    9. France Drug Eluting Stents (Des) Landscape Analysis

    • 9.1 France Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 9.2 France Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    10. Italy Drug Eluting Stents (Des) Landscape Analysis

    • 10.1 Italy Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 10.2 Italy Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    11. Spain Drug Eluting Stents (Des) Landscape Analysis

    • 11.1 Spain Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 11.2 Spain Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    12. Poland Drug Eluting Stents (Des) Landscape Analysis

    • 12.1 Poland Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 12.2 Poland Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    13. Russia Drug Eluting Stents (Des) Landscape Analysis

    • 13.1 Russia Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 13.2 Russia Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    14. Switzerland Drug Eluting Stents (Des) Landscape Analysis

    • 14.1 Switzerland Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 14.2 Switzerland Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    15. Turkey Drug Eluting Stents (Des) Landscape Analysis

    • 15.1 Turkey Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 15.2 Turkey Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 16.3.2 Finland Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 16.3.3 Norway Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 16.3.4 Sweden Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 16.3.6 Iceland Drug Eluting Stents (Des) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 17.3.2 Netherlands Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Drug Eluting Stents (Des) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 18.3.2 Latvia Drug Eluting Stents (Des) Market Volume and Growth Rate

      • 18.3.3 Lithuania Drug Eluting Stents (Des) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Reva Medical

      • 19.1.1 Reva Medical Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Kinhely

      • 19.2.1 Kinhely Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 JW Medical Systems

      • 19.3.1 JW Medical Systems Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Essen

      • 19.4.1 Essen Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Terumo Medical

      • 19.5.1 Terumo Medical Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Translumina

      • 19.6.1 Translumina Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sahajanand

      • 19.7.1 Sahajanand Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Medtronic Vascular

      • 19.8.1 Medtronic Vascular Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Abbott Laboratories

      • 19.9.1 Abbott Laboratories Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Biosensors

      • 19.10.1 Biosensors Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Sino Medical

      • 19.11.1 Sino Medical Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Advantec Vascular

      • 19.12.1 Advantec Vascular Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 MicroPort Medical

      • 19.13.1 MicroPort Medical Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Medfavour Medical

      • 19.14.1 Medfavour Medical Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Abbott Vascular

      • 19.15.1 Abbott Vascular Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Vascular Concepts

      • 19.16.1 Vascular Concepts Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 B.Braun Melsengen AG

      • 19.17.1 B.Braun Melsengen AG Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Orbusneich

      • 19.18.1 Orbusneich Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Blue Medical

      • 19.19.1 Blue Medical Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 MIV Therapeutics

      • 19.20.1 MIV Therapeutics Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Relisys Medical

      • 19.21.1 Relisys Medical Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Sorin

      • 19.22.1 Sorin Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Boston Scientific

      • 19.23.1 Boston Scientific Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Promed Medical

      • 19.24.1 Promed Medical Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Lepu Medical

      • 19.25.1 Lepu Medical Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 DISA Vascular

      • 19.26.1 DISA Vascular Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    The List of Tables and Figures (Totals 67 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Cobalt-chromium alloy Stents from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Magnesium alloy Stents from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Tyrosine polycarbonate Stents from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Nitinol Stents from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Platinum chromium alloy Stents from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Stainless steel Stents from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Other Materials from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Coronary Heart Disease from 2014 to 2026

    • Figure Europe Drug Eluting Stents (Des) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure France Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Drug Eluting Stents (Des) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Drug Eluting Stents (Des) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Drug Eluting Stents (Des)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Drug Eluting Stents (Des) by Different Types from 2014 to 2026

    • Table Consumption Share of Drug Eluting Stents (Des) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Cobalt-chromium alloy Stents

    • Figure Market Size and Growth Rate of Magnesium alloy Stents

    • Figure Market Size and Growth Rate of Tyrosine polycarbonate Stents

    • Figure Market Size and Growth Rate of Nitinol Stents

    • Figure Market Size and Growth Rate of Platinum chromium alloy Stents

    • Figure Market Size and Growth Rate of Stainless steel Stents

    • Figure Market Size and Growth Rate of Other Materials

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Drug Eluting Stents (Des) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Drug Eluting Stents (Des) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Coronary Heart Disease

    • Figure Market Size and Growth Rate of Others

    • Table Europe Drug Eluting Stents (Des) Production by Major Regions

    • Table Europe Drug Eluting Stents (Des) Production Share by Major Regions

    • Figure Europe Drug Eluting Stents (Des) Production Share by Major Countries and Regions in 2014

    • Table Europe Drug Eluting Stents (Des) Consumption by Major Regions

    • Table Europe Drug Eluting Stents (Des) Consumption Share by Major Regions

    • Table Germany Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table UK Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table France Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Italy Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Spain Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Poland Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Russia Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Switzerland Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Turkey Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Drug Eluting Stents (Des) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Germany Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Germany Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Germany Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table UK Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table UK Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table UK Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table UK Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table France Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table France Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table France Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table France Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Italy Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Italy Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Italy Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Spain Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Spain Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Spain Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Poland Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Poland Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Poland Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Russia Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Russia Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Russia Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Switzerland Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Turkey Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Turkey Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Turkey Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Drug Eluting Stents (Des) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Drug Eluting Stents (Des) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Drug Eluting Stents (Des) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Drug Eluting Stents (Des) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Reva Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reva Medical

    • Figure Sales and Growth Rate Analysis of Reva Medical

    • Figure Revenue and Market Share Analysis of Reva Medical

    • Table Product and Service Introduction of Reva Medical

    • Table Company Profile and Development Status of Kinhely

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kinhely

    • Figure Sales and Growth Rate Analysis of Kinhely

    • Figure Revenue and Market Share Analysis of Kinhely

    • Table Product and Service Introduction of Kinhely

    • Table Company Profile and Development Status of JW Medical Systems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JW Medical Systems

    • Figure Sales and Growth Rate Analysis of JW Medical Systems

    • Figure Revenue and Market Share Analysis of JW Medical Systems

    • Table Product and Service Introduction of JW Medical Systems

    • Table Company Profile and Development Status of Essen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Essen

    • Figure Sales and Growth Rate Analysis of Essen

    • Figure Revenue and Market Share Analysis of Essen

    • Table Product and Service Introduction of Essen

    • Table Company Profile and Development Status of Terumo Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo Medical

    • Figure Sales and Growth Rate Analysis of Terumo Medical

    • Figure Revenue and Market Share Analysis of Terumo Medical

    • Table Product and Service Introduction of Terumo Medical

    • Table Company Profile and Development Status of Translumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Translumina

    • Figure Sales and Growth Rate Analysis of Translumina

    • Figure Revenue and Market Share Analysis of Translumina

    • Table Product and Service Introduction of Translumina

    • Table Company Profile and Development Status of Sahajanand

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sahajanand

    • Figure Sales and Growth Rate Analysis of Sahajanand

    • Figure Revenue and Market Share Analysis of Sahajanand

    • Table Product and Service Introduction of Sahajanand

    • Table Company Profile and Development Status of Medtronic Vascular

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic Vascular

    • Figure Sales and Growth Rate Analysis of Medtronic Vascular

    • Figure Revenue and Market Share Analysis of Medtronic Vascular

    • Table Product and Service Introduction of Medtronic Vascular

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Biosensors

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biosensors

    • Figure Sales and Growth Rate Analysis of Biosensors

    • Figure Revenue and Market Share Analysis of Biosensors

    • Table Product and Service Introduction of Biosensors

    • Table Company Profile and Development Status of Sino Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sino Medical

    • Figure Sales and Growth Rate Analysis of Sino Medical

    • Figure Revenue and Market Share Analysis of Sino Medical

    • Table Product and Service Introduction of Sino Medical

    • Table Company Profile and Development Status of Advantec Vascular

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantec Vascular

    • Figure Sales and Growth Rate Analysis of Advantec Vascular

    • Figure Revenue and Market Share Analysis of Advantec Vascular

    • Table Product and Service Introduction of Advantec Vascular

    • Table Company Profile and Development Status of MicroPort Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MicroPort Medical

    • Figure Sales and Growth Rate Analysis of MicroPort Medical

    • Figure Revenue and Market Share Analysis of MicroPort Medical

    • Table Product and Service Introduction of MicroPort Medical

    • Table Company Profile and Development Status of Medfavour Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medfavour Medical

    • Figure Sales and Growth Rate Analysis of Medfavour Medical

    • Figure Revenue and Market Share Analysis of Medfavour Medical

    • Table Product and Service Introduction of Medfavour Medical

    • Table Company Profile and Development Status of Abbott Vascular

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Vascular

    • Figure Sales and Growth Rate Analysis of Abbott Vascular

    • Figure Revenue and Market Share Analysis of Abbott Vascular

    • Table Product and Service Introduction of Abbott Vascular

    • Table Company Profile and Development Status of Vascular Concepts

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vascular Concepts

    • Figure Sales and Growth Rate Analysis of Vascular Concepts

    • Figure Revenue and Market Share Analysis of Vascular Concepts

    • Table Product and Service Introduction of Vascular Concepts

    • Table Company Profile and Development Status of B.Braun Melsengen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of B.Braun Melsengen AG

    • Figure Sales and Growth Rate Analysis of B.Braun Melsengen AG

    • Figure Revenue and Market Share Analysis of B.Braun Melsengen AG

    • Table Product and Service Introduction of B.Braun Melsengen AG

    • Table Company Profile and Development Status of Orbusneich

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orbusneich

    • Figure Sales and Growth Rate Analysis of Orbusneich

    • Figure Revenue and Market Share Analysis of Orbusneich

    • Table Product and Service Introduction of Orbusneich

    • Table Company Profile and Development Status of Blue Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Blue Medical

    • Figure Sales and Growth Rate Analysis of Blue Medical

    • Figure Revenue and Market Share Analysis of Blue Medical

    • Table Product and Service Introduction of Blue Medical

    • Table Company Profile and Development Status of MIV Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MIV Therapeutics

    • Figure Sales and Growth Rate Analysis of MIV Therapeutics

    • Figure Revenue and Market Share Analysis of MIV Therapeutics

    • Table Product and Service Introduction of MIV Therapeutics

    • Table Company Profile and Development Status of Relisys Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Relisys Medical

    • Figure Sales and Growth Rate Analysis of Relisys Medical

    • Figure Revenue and Market Share Analysis of Relisys Medical

    • Table Product and Service Introduction of Relisys Medical

    • Table Company Profile and Development Status of Sorin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorin

    • Figure Sales and Growth Rate Analysis of Sorin

    • Figure Revenue and Market Share Analysis of Sorin

    • Table Product and Service Introduction of Sorin

    • Table Company Profile and Development Status of Boston Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Scientific

    • Figure Sales and Growth Rate Analysis of Boston Scientific

    • Figure Revenue and Market Share Analysis of Boston Scientific

    • Table Product and Service Introduction of Boston Scientific

    • Table Company Profile and Development Status of Promed Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Promed Medical

    • Figure Sales and Growth Rate Analysis of Promed Medical

    • Figure Revenue and Market Share Analysis of Promed Medical

    • Table Product and Service Introduction of Promed Medical

    • Table Company Profile and Development Status of Lepu Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lepu Medical

    • Figure Sales and Growth Rate Analysis of Lepu Medical

    • Figure Revenue and Market Share Analysis of Lepu Medical

    • Table Product and Service Introduction of Lepu Medical

    • Table Company Profile and Development Status of DISA Vascular

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DISA Vascular

    • Figure Sales and Growth Rate Analysis of DISA Vascular

    • Figure Revenue and Market Share Analysis of DISA Vascular

    • Table Product and Service Introduction of DISA Vascular

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US